Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
auto-injector
Pharma
FDA approves Pfizer's injected Hympavzi for hemophilia A or B
The FDA has approved Pfizer's Hympavzi, an anti-tissue factor pathway inhibitor for patients age 12 and older with hemophilia A or B.
Kevin Dunleavy
Oct 11, 2024 4:20pm
PCI puts $365M-plus into multiple US, EU manufacturing projects
Sep 24, 2024 12:48pm
ARS has 'blue sky opportunity' in launching neffy, analyst says
Aug 21, 2024 12:48pm
Biogen, Eisai kick off rolling FDA submission for subQ Leqembi
May 14, 2024 7:51pm
SHL lands financial support for drug delivery growth strategy
Dec 13, 2022 8:00am
Novartis' Sandoz eyes EMA nod for high-concentration Humira copy
Jun 20, 2022 9:50am
